PVPablo Villar-Calle

Pablo Villar-Calle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pablo Villar-Calle has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • RACI: A Novel Prognostic Marker in Functional Tricuspid Regurgitation

    by Robert S. Zhang, Giorgia Falco, Emily Li, Pablo Villar-Calle, Mahniz Reza, Edmund Naami, Elizabeth Manowitz, Prianca Tawde, Radhika Narasimhan, Mojdeh Yadollahikhales, et al.

    BACKGROUND: Right atrioventricular coupling index (RACI), defined as the ratio of right atrial (RA) to right ventricular (RV) end-diastolic volume on cardiac magnetic resonance, is a novel parameter that reflects RA–RV hemodynamic interplay. Its prognostic value in functional tricuspid regurgitation (TR) is unknown. METHODS: This study included 633 consecutive patients with moderate or greater functional TR undergoing cardiac magnetic resonance. Patients were stratified into 2 groups based on the optimal cutoff by the Youden index (normal: RACIP 2 versus 55.4 [interquartile range, 42.6–69.0] mL/m 2 ; P 2 ; P =0.012), and no difference in RV function (RV ejection fraction: 46.3±9.8% versus 45.4±12.7%; P =0.43). Over a median follow-up of 2.9 years (interquartile range, 0.7–6.9), a high RACI was associated with increased mortality risk (25% versus 15%; hazard ratio, 2.06 [95% CI, 1.47–2.90]; P P =0.014). In addition, RACI provided incremental prognostic value for predicting the primary outcome over conventional right heart indices (RA and RV volumes, RV ejection fraction, TR severity), improving model performance (χ 2 increased from 28.5 to 37.6; P =0.003). CONCLUSIONS: RACI is a novel parameter that effectively integrates RA and RV remodeling, and independently predicts all-cause mortality in functional TR. Incorporating RACI into clinical assessment may help with improving risk stratification and guiding the timing of intervention in patients with functional TR.


  • Hepatic Extracellular Volume Fraction by CMR: A Novel Prognostic Marker in Tricuspid Regurgitation

    by Pablo Villar-Calle, Robert S. Zhang, Edmund Naami, Lorenzo Sewanan, Mahniz Reza, Elizabeth Manowitz, Nicholas Chan, Pascal Spincemaille, Yi Wang, Jonathan W. Weinsaft, et al.

    BACKGROUND: Tricuspid regurgitation (TR) leads to systemic venous congestion and congestive hepatopathy, but conventional TR imaging parameters incompletely capture systemic consequences. Hepatic extracellular volume fraction (ECV) on cardiac magnetic resonance T1 mapping may reflect hepatic tissue remodeling and provide prognostic information beyond conventional risk markers. METHODS: Consecutive patients with moderate or greater TR who underwent cardiac magnetic resonance with hepatic T1 mapping were studied. Hepatic ECV was calculated using pre- and postcontrast T1 values and hematocrit. Patients were stratified by hepatic ECV tertiles. The primary end point was all-cause mortality. RESULTS: Among 234 patients (mean age, 65.6±15.8 years; 46.2% men), mean hepatic ECV was 37.7±9.0%, with tertile cutoffs at 32.5% and 41.3%. Higher hepatic ECV tertiles were associated with worse biventricular function and greater TR severity. Right ventricular ejection fraction decreased across tertiles (48.2% versus 48.5% versus 40.3%, P P P P =0.002 for trend). Kaplan-Meier analysis showed 3-year survival rates of 88%, 89%, and 57% across tertiles 1, 2, and 3, respectively. In multivariable Cox regression adjusting for age, right ventricular dysfunction, and severe TR, hepatic ECV tertiles remained independently predictive of mortality (hazard ratio, 1.62 [95% CI, 1.06–2.48]; P =0.027). Forward stepwise analysis yielded significant incremental prognostic value beyond traditional TR risk factors, improving model discrimination from χ²=24.4 to 30.1 ( P =0.02). CONCLUSIONS: Hepatic ECV is a novel prognostic marker that provides incremental risk stratification in TR and has potential to impact therapeutic decision-making in the era of expanded treatment options for TR.


  • Tissue-Based Predictors of Impaired Right Ventricular Strain in Coronary Artery Disease: A Multicenter Stress Perfusion Study

    by Pablo Villar-Calle, Jonathan D. Kochav, Krista Vadaketh, Caitlin Chiu, Katherine Tak, Hannah Agoglia, Nicole Liberman, Kenny L. Nguyen, Abdier Vizcarra-Tellez, Alan Wu, et al.

    BACKGROUND: Right ventricular (RV) dysfunction is known to impact prognosis, but its determinants in coronary artery disease are poorly understood. Stress cardiac magnetic resonance (CMR) has been used to assess ischemia and infarction in relation to the left ventricle (LV); the impact of myocardial tissue properties on RV function is unknown. METHODS: Vasodilator stress CMR was performed in patients with known coronary artery disease at 7 sites between May 2005 and October 2018. Myocardial infarction was identified on late gadolinium enhancement-CMR, and infarct transmurality was graded on a per-segment basis. Ischemia was assessed on stress CMR based on first-pass perfusion and localized by using segment partitions corresponding to cine and late gadolinium enhancement analyses. RV function was evaluated by CMR-feature tracking for primary analysis with a global longitudinal strain threshold of 20% used to define impaired RV strain (RV IS ); secondary functional analysis via RV ejection fraction was also performed. RESULTS: A total of 2604 patients were studied, among whom RV IS was present in 461 patients (18%). The presence and magnitude of RV IS were strongly associated with LV dysfunction, irrespective of whether measured by LV ejection fraction or wall motion score ( P IS (both P P IS conferred increased mortality risk (hazard ratio, 1.35 [95% CI, 1.11–1.66]; P =0.003) even after controlling for LV function, infarction, and ischemia. CONCLUSIONS: RV IS in patients with known coronary artery disease is associated with potentially reversible LV processes, including LV functional impairment due to ischemic and predominantly viable myocardium, which confers increased mortality risk independent of LV function and tissue substrate.


  • Open Access

    Abnormal Mechanics Relate to Myocardial Fibrosis and Ventricular Arrhythmias in Patients With Mitral Valve Prolapse

    by Yasufumi Nagata, Philippe B. Bertrand, Vinit Baliyan, Jonathan Kochav, Ruth D. Kagan, Kristian Ujka, Hassan Alfraidi, Antonia van Kampen, Jordan E. Morningstar, Jacob P. Dal-Bianco, et al.

    Background: The relation between ventricular arrhythmia and fibrosis in mitral valve prolapse (MVP) is reported, but underlying valve-induced mechanisms remain unknown. We evaluated the association between abnormal MVP-related mechanics and myocardial fibrosis, and their association with arrhythmia. Methods: We studied 113 patients with MVP with both echocardiogram and gadolinium cardiac magnetic resonance imaging for myocardial fibrosis. Two-dimensional and speckle-tracking echocardiography evaluated mitral regurgitation, superior leaflet and papillary muscle displacement with associated exaggerated basal myocardial systolic curling, and myocardial longitudinal strain. Follow-up assessed arrhythmic events (nonsustained or sustained ventricular tachycardia or ventricular fibrillation). Results: Myocardial fibrosis was observed in 43 patients with MVP, predominantly in the basal-midventricular inferior-lateral wall and papillary muscles. Patients with MVP with fibrosis had greater mitral regurgitation, prolapse, and superior papillary muscle displacement with basal curling and more impaired inferior-posterior basal strain than those without fibrosis ( P P 6-month follow-up developed ventricular arrhythmias associated (univariable) with fibrosis, greater prolapse, mitral annular disjunction, and double-peak strain. In multivariable analysis, double-peak strain showed incremental risk of arrhythmia over fibrosis. Conclusions: Basal inferior-posterior myocardial fibrosis in MVP is associated with abnormal MVP-related myocardial mechanics, which are potentially associated with ventricular arrhythmia. These associations suggest pathophysiological links between MVP-related mechanical abnormalities and myocardial fibrosis, which also may relate to ventricular arrhythmia and offer potential imaging markers of increased arrhythmic risk.


  • Open Access

    Body fat and metabolic age as indicators of inflammation and cardiovascular risk

    by Juan C Garcia-Rubira, Francisco J Cano-Garcia, Beatriz Bullon, Tania Seoane, Pablo V Villar, Mario D Cordero, Pedro Bullon